Docetaxel (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Docetaxel drug offered from Sagent Pharmaceuticals. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | Docetaxel Anhydrous |
| SUBSTANCE NAME: | DOCETAXEL ANHYDROUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-15 |
| END MARKETING DATE: | 0000-00-00 |
Docetaxel HUMAN PRESCRIPTION DRUG Details:
| Item Description | Docetaxel from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2017-09-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-245_b504a8c4-0bcd-42ba-9794-ea0c11b001a1 |
| PRODUCT NDC: | 25021-245 |
| APPLICATION NUMBER: | ANDA207252 |
Other DOCETAXEL ANHYDROUS Pharmaceutical Manufacturers / Labelers:
